Syngene is delighted to announce that its Dymension 2D image analysis software is being used by scientists at the world renowned, Georgetown University Medical Center (GUMC)
in Washington DC to rapidly assess molecular mechanisms of novel pro-drugs on breast cancer cells. Researchers are using Dymension, currently claiming to be the fastest 2D protein
gel analysis software on the market, to analyse images of Coomassie Blue stained proteins derived from breast cancer cell lines (MCF7 and  MDA MB231) after treatment with an 8-Quinolinyl histone deacetylase inhibitor. From the analysis, GUMC scientists have isolated many proteins that are significantly up or down-regulated, which could provide information about the drug’s molecular targets and molecular mechanisms in cancer treatment.